Thomasville National Bank’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.7K Buy
+13,350
New +$32.3K ﹤0.01% 241
2025
Q4
$31.9K Hold
13,350
﹤0.01% 235
2025
Q3
$35.5K Hold
13,350
﹤0.01% 251
2025
Q2
$39.6K Hold
13,350
﹤0.01% 223
2025
Q1
$43.3K Hold
13,350
﹤0.01% 233
2024
Q4
$52.7K Hold
13,350
﹤0.01% 233
2024
Q3
$103K Hold
13,350
0.01% 234
2024
Q2
$68.6K Hold
13,350
0.01% 234
2024
Q1
$109K Hold
13,350
0.01% 235
2023
Q4
$53.4K Hold
13,350
﹤0.01% 234
2023
Q3
$55K Hold
13,350
0.01% 225
2023
Q2
$79.3K Hold
13,350
0.01% 226
2023
Q1
$46.1K Hold
13,350
﹤0.01% 228
2022
Q4
$47K Hold
13,350
0.01% 208
2022
Q3
$48K Hold
13,350
0.01% 201
2022
Q2
$75K Hold
13,350
0.01% 206
2022
Q1
$115K Hold
13,350
0.01% 215
2021
Q4
$149K Hold
13,350
0.01% 216
2021
Q3
$173K Hold
13,350
0.02% 208
2021
Q2
$221K Buy
+13,350
New +$226K 0.02% 201
2021
Q1
Sell
-13,650
Closed -$218K 212
2020
Q4
$218K Buy
+13,650
New +$252K 0.03% 184

Other funds holding XBIT

Thomasville National Bank's XBIT Position: Q2 2026 in Review

Thomasville National Bank opened a new position in XBiotech (XBIT) in Q2 2026: 13,350 shares worth $30.7K. The stake represents ﹤0.01% of the portfolio and ranks #241 among its holdings. This is a return to the name: Thomasville National Bank previously reported a position in XBIT as recently as Q4 2025.

Thomasville National Bank first reported a position in XBIT in Q4 2020 and has held it in 21 quarters since. The position peaked at $221K in Q2 2021. 2 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • Thomasville National Bank held 13,350 shares of XBiotech worth $30.7K as of Q2 2026.
  • XBiotech was a new Thomasville National Bank position in Q2 2026.
  • XBiotech made up ﹤0.01% of Thomasville National Bank's portfolio in Q2 2026, its #241 holding.
  • Thomasville National Bank first reported a position in XBiotech in Q4 2020 and has held it in 21 quarters since.
  • Thomasville National Bank's XBiotech position peaked at $221K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on Thomasville National Bank's 13F filing for Q2 2026, filed 20 Jul 2026.